In-silico analysis of identified proteins from HER-2 positive breast cancer cell lines resistant and sensitive to Trastuzumab treatment

In-silico analysis of identified proteins from HER-2 positive breast cancer cell lines resistant and sensitive to Trastuzumab treatment

In-silico analysis of identified proteins from HER-2 positive breast cancer cell lines resistant and sensitive to Trastuzumab treatment 2425 2560 Metabolism & Cancer
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.